Patents by Inventor Dan Gelvan

Dan Gelvan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170216217
    Abstract: In one embodiment, the present invention provides a composition comprising a plurality of microcapsules, each comprising a shell and a core carrying an active agent selected from the group consisting of: (a) a non-hydrophilic active agent and (b) a hydrophilic active agent dissolved or suspended in an oil; wherein the shell comprises a polymeric coating, and wherein at least a portion of the microcapsules in a sample of the composition are spherical when the sample of the microcapsules is viewed in a scanning electron microscope with a magnification in the range of between ×2000 and ×50000.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 3, 2017
    Applicant: I2O Pharma Ltd.
    Inventors: Michel Afargan, Dan Gelvan, Natalia Naraykin
  • Publication number: 20110304240
    Abstract: This present invention provides a power supply for implanting into a patient's body and providing electricity to a load within the body, said power supply comprising an enclosure; adapted for optimizing an activating force by mechanisms of orienting thereof; the power supply further comprising (a) a piezoelectric micro-generator comprising (b) electrical energy storing means; (c) control unit adapted for managing charging and discharging said storing means said control unit further provided with means for decoupling said piezoelectric element from and connecting to said electrical energy storing means to increase efficiency of said power supply.
    Type: Application
    Filed: December 21, 2009
    Publication date: December 15, 2011
    Applicant: SIRIUS IMPLANTABLE SYSTEMS LTD.
    Inventors: Arieh Meitav, Dan Gelvan
  • Publication number: 20110040248
    Abstract: A medication, method and device for cardiac treatment are provided, in particular, for treating supraventricular arrhythmias. Specifically, a method is provided for treating supraventricular arrhythmias, using a therapeutically effective amount of a cholinergic receptor agonist, for example, acetylcholine. This device may be part of universal device which provides pacing and defibrillation. In particular, the present invention can be used to treat atrial fibrillation, atrial flutter and atrial tachycardia by a bolus injection of a rapidly hydrolysable cholinergic receptor agonist such as acetylcholine.
    Type: Application
    Filed: August 17, 2010
    Publication date: February 17, 2011
    Applicant: CLOSED LOOP THERAPIES BV
    Inventors: Eli Ovsyshcher, Ilya A. Fleidervish, Dan Gelvan
  • Patent number: 7781402
    Abstract: A medication, method and device for cardiac treatment are provided, in particular, for treating supraventricular arrhythmias. Specifically, a method is provided for treating supraventricular arrhythmias, using a therapeutically effective amount of a cholinergic receptor agonist, for example, acetylcholine. This device may be part of universal device which provides pacing and defibrillation. In particular, the present invention can be used to treat atrial fibrillation, atrial flutter and atrial tachycardia by a bolus injection of a rapidly hydrolysable cholinergic receptor agonist such as acetylcholine.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: August 24, 2010
    Assignee: Closed Loop Therapies Ltd.
    Inventors: Eli Ovsyshcher, Ilya A. Fleidervish, Yuri Goldberg, Vladimir Zeldets, Dan Gelvan
  • Publication number: 20060079941
    Abstract: A medication, method and device for cardiac treatment are provided, in particular, for treating supraventricular arrhythmias. Specifically, a method is provided for treating supraventricular arrhythmias, using a therapeutically effective amount of a cholinergic receptor agonist, for example, acetylcholine. This device maybe part of universal device which provides pacing and defibrillation. In particular, the present invention can be used to treat atrial fibrillation, atrial flutter and atrial tachycardia by a bolus injection of a rapidly hydrolysable cholinergic receptor agonist such as acetylcholine.
    Type: Application
    Filed: October 11, 2005
    Publication date: April 13, 2006
    Inventors: Eli Ovsyshcher, Ilya Fleidervish, Yuri Goldberg, Vladimir Zeldets, Dan Gelvan